Company Profiles

driven by the PitchBook Platform

Metaclipse Therapeutics

Description

Operator of a pre-clinical stage biotechnology company. The company is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with proven immunostimulatory molecules.

2011

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$200k

Total Amount Raised

6

Investors

Description

Operator of a pre-clinical stage biotechnology company. The company is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with proven immunostimulatory molecules.

Website:

www.metaclipse.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Therapeutic Devices

Primary Office

3175 Presidential Drive Atlanta, GA 30340United States +1 (404) 380-1342
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Metaclipse Therapeutics's full profile, request a free trial.

Metaclipse Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Metaclipse Therapeutics Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biotechnology and Biological Science Research CouncilLimited Partner000 0000000 0000
Georgia Research AllianceGovernment000 0000000 0000
JLabsAccelerator/Incubator000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Biotechnology and Biological Science Research Council Limited Partner
Georgia Research Alliance Government
JLabs Accelerator/Incubator
National Cancer Institute Government
National Institutes of Health Government

Metaclipse Therapeutics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Shaker ReddyCo-Founder, President, Chief Operating Officer & Board Member
Periasamy Selvaraj Ph.DChief Scientific Officer & Co-Founder
Kamal Kannan Ph.DVice President, Product Development & Consultant
Dawn Eberhardt Ph.DDirector of Quality Control
Shaker Reddy Co-Founder, President, Chief Operating Officer & Board Member
Periasamy Selvaraj Ph.D Chief Scientific Officer & Co-Founder
Kamal Kannan Ph.D Vice President, Product Development & Consultant
Dawn Eberhardt Ph.D Director of Quality Control

Metaclipse Therapeutics Board Members (1)

NameRepresentingRoleSinceContact
Info
Shaker ReddyMetaclipse TherapeuticsCo-Founder, President, Chief Operating Officer & Board Member000 0000
Shaker Reddy Co-Founder, President, Chief Operating Officer & Board Member Metaclipse Therapeutics
Request full access to PitchBook